Preventive effects of intermittent administration of human parathyroid hormone on steroid-induced osteopenia in rats

Journal of Orthopaedic Science

Volumn 1, Issue 5, 1996, Pages 318-328

  Miyakoshi, Naohisa ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Bone histomorphometry; Human parathyroid hormone; Steroid induced osteopenia

Indexed keywords

EID: 0001508138     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02348842     Document Type: Article

References (23)

1. Avioli LV. Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption. Adv Exp Med Biol 1984;171:81-9.
2. Bradbeer JN, Arlot ME, Meunier PJ, et al. Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol 1992;37:282-9.
3. Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 1983;35:410-7.
4. Hahn TJ. Corticosteroid-induced osteopenia. Arch Intern Med 1978;138:882-5.
5. Hashimoto J, Yoshikawa H, Takaoka K. Hormonal factors in osteoporosis (in Japanese). Seikeigeka (Orthop Surg) 1992;43:1037-45.
6. Hock JM, Hummert JR, Boyce R, et al. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo. J Bone Miner Res 1989;4:449-58.
7. Horiuchi N, Rosenblatt M, Keutmann HT, et al. A multiresponse parathyroid hormone assay: An inhibitor has agonist properties in vivo. Am J Physiol 1983;244:E589-95.
8. Inoue J. Bone changes with long-term administration of low-dose 1-34 human PTH in adult beagles (in Japanese). J Jpn Orthop Assoc 1985;59:409-27.
9. Liu CC, Kalu DN. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 1990;5:973-82.
10. Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-90.
11. Mosekilde L, Søgaard CH, Danielsen CC, et al. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: A comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 1991:129:421-8.
12. Nakamura Y, Yamaguchi A, Ikeda T, et al. Acid phosphatase activity is detected preferentially in the osteoclastic lineage by pretreatment with cyanuric chloride. J Histochem Cytochem 1991;39:1415-20.
13. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 1987;2:595-610.
14. Podbesek R, Edouard C, Meunier PJ, et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 1983;112:1000-6.
15. Reeve J, Davies UM, Hesp R, et al. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. BMJ 1990;301:314-8.
16. Sato T, Sato K, Nagasawa T, et al. Effect of intermittent administration of human parathyroid hormone (1-34) on bone change in ovariectomized and streptozotocin-induced diabetes mellitus rats (in Japanese). J Jpn Soc Bone Morphometry 1993;3:55-62.
17. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986;1:377-81.
18. Suzuki Y, Ichikawa Y, Saito E, et al. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
19. Takahashi HE, Tanizawa T, Hori M, et al. Effect of intermittent administration of human parathyroid hormone (1-34) on experimental osteopenia of rats induced by ovariectomy. Cells and Materials [Suppl] 1991;1:113-7.
20. Tam CS, Heersche JNM, Murray TM, et al. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 1982;110:506-12.
21. Tanizawa T, Takahashi H, Hanyu T, et al. Histomorphometric profile, effect of glucocorticoid treatment on human trabecular bone packets of ilium. In: Fujita T, Yoshimoto Y, editors. Kotsukeitaikeisoku (Bone morphometry) vol. 7 (in Japanese). Kotsu no Sokutei (Measurements of bone) Tokyo: Nishimura, 1990:89-96.
22. Tanizawa T. Histomorphometry of tibia and vertebral body in rats (in Japanese). J Jpn Soc Bone Morphometry 1994;4:13-6.
23. Unoki E. Effect of human PTH on steroid-induced osteopenia: A histomorphometric study of decalcified and undecalcified trabecular bone in rat (in Japanese). J Jpn Orthop Assoc 1995;69:1064-75.